Fulcrum Therapeutics, Inc.
FULC
Jodie situation report
Fulcrum Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 3 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- FULC's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if FULC's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind FULC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
SNYSanofipartnerApr 27, 2026 ▾
“In May 2024, we entered into a collaboration and license agreement with Sanofi, pursuant to which we granted Sanofi an exclusive license under certain intellectual property rights to commercialize losmapimod, an oral small molecule for the treatment of facios…”
CAMPFiling-linked namepartnerFeb 24, 2026 ▾
“CAMP4 Agreement In July 2023, the Company entered into a license agreement (the “CAMP4 Agreement”) with CAMP4 Therapeutics Corporation (“CAMP4”) pursuant to which the Company received a worldwide exclusive license (including the right to sublicense) from CAMP…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
FULC is currently a Leader in the organic co-movement group Oil & Gas Equipment. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for FULC; it is not active in the latest market snapshot.